Exelixis | EXEL - Net Income

Exelixis reported $-30173000 in Net Income for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Net Income Change
Acadia Pharmaceuticals ACAD:US USD -41725000 14.54M
Agios Pharmaceuticals AGIO:US USD 36.53M 118.27M
Akebia Therapeutics AKBA:US USD -7552000 44.31M
Amgen AMGN:US USD 1.62B 527M
AstraZeneca AZN:LN USD 901M 739M
Bayer BAYN:GR EUR 611M 65M
Biomarin Pharmaceutical BMRN:US USD -249000 6.4M
Bluebird Bio BLUE:US USD -76520000 23.62M
Bristol Myers Squibb BMY:US USD 2.02B 416M
Cytokinetics CYTK:US USD -137380000 4.93M
Eisai 4523:JP JPY 8.64B 5.07B
Eli Lilly And LLY:US USD 1.94B 486M
Esperion Therapeutics ESPR:US USD -55487000 370K
Exelixis EXEL:US USD -30173000 103.38M
Genmab GEN:DC DKK 584M 2B
Glaxosmithkline GSK:US GBP 1.5B 8.82B
Immunogen IMGN:US USD -59008000 18.75M
IONIS PHARMACEUT IONS:US USD -52430000 5.44M
Macrogenics MGNX:US USD 12.8M 37.61M
Merk MRK:US USD 3.02B 231M
Mirati Therapeutics MRTX:US USD -202475000 28.91M
Moderna Inc MRNA:US USD 1.46B 422M
Nektar Therapeutics NKTR:US USD -59688000 639K
Neurocrine Biosciences NBIX:US USD 89M 20.5M
Novartis NOVN:VX USD 1.47B 107M
Pfizer PFE:US USD 5B 3.61B
Puma Biotechnology PBYI:US USD -5606000 5.25M
Seattle Genetics SGEN:US USD -148171000 42.64M
Takeda 4502:JP JPY 119.13B 57.39B
Ultragenyx Pharmaceutical RARE:US USD -151833000 93.27M
Xencor XNCR:US USD -12042000 20.72M
YTE INCY:US USD 28.46M 84.31M